A meta-analysis [57] reported a general reduction in mortality (approximately 21 %) in adult patients with sepsis and septic shock who received polyclonal Igs and a more evident effect on mortality in the subgroup receiving IgM-enriched immunoglobulin. The gene discussed is CD40LG; the disease is Sepsis.